- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.2: 7 residues within 4Å:- Chain A: F.536, Y.544, F.595, I.819
- Chain E: G.625
- Ligands: PLM.3, POV.4
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.595, A:I.819
OLC.12: 7 residues within 4Å:- Chain D: F.536, Y.544, F.595, I.819
- Chain F: G.625
- Ligands: PLM.13, POV.14
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:F.595, D:I.819
OLC.16: 10 residues within 4Å:- Chain D: R.620, I.621
- Chain E: L.540, Y.545, F.596, L.603, I.820
- Ligands: PLM.17, PLM.20, POV.21
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:F.596, E:L.603, E:I.820
OLC.23: 10 residues within 4Å:- Chain A: R.620, I.621
- Chain F: L.540, Y.545, F.596, L.603, I.820
- Ligands: PLM.24, PLM.27, POV.28
3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:F.596, F:L.603, F:I.820
- 14 x PLM: PALMITIC ACID(Non-covalent)(Non-functional Binders)
PLM.3: 9 residues within 4Å:- Chain A: Y.544, W.547, M.548, V.551, Y.554, L.602, F.605
- Chain E: F.629
- Ligands: OLC.2
7 PLIP interactions:1 interactions with chain E, 6 interactions with chain A- Hydrophobic interactions: E:F.629, A:W.547, A:W.547, A:V.551, A:Y.554, A:L.602, A:F.605
PLM.5: 5 residues within 4Å:- Chain B: Y.206
- Chain E: M.549, V.552
- Ligands: PLM.17, PLM.20
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:V.552
PLM.6: 5 residues within 4Å:- Chain B: V.217, V.220, L.221, N.224
- Ligands: PLM.18
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:V.217, B:V.220, B:L.221
PLM.8: 5 residues within 4Å:- Chain C: Y.206
- Chain F: M.549, V.552
- Ligands: PLM.24, PLM.27
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:V.552
PLM.9: 5 residues within 4Å:- Chain C: V.217, V.220, L.221, N.224
- Ligands: PLM.25
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:V.217, C:V.220, C:L.221
PLM.13: 8 residues within 4Å:- Chain D: Y.544, W.547, M.548, Y.554, L.602, F.605
- Chain F: F.629
- Ligands: OLC.12
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain F- Hydrophobic interactions: D:W.547, D:W.547, D:Y.554, D:L.602, D:F.605, F:F.629
PLM.17: 5 residues within 4Å:- Ligands: PLM.5, OLC.16, PLM.18, PLM.20, POV.21
No protein-ligand interaction detected (PLIP)PLM.18: 5 residues within 4Å:- Chain E: G.594, I.595, F.596
- Ligands: PLM.6, PLM.17
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:F.596, E:F.596
- Hydrogen bonds: E:I.595
PLM.19: 5 residues within 4Å:- Chain D: C.549
- Chain E: L.811, Y.819, I.822, L.825
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:L.811, E:Y.819, E:I.822, E:L.825
PLM.20: 10 residues within 4Å:- Chain E: Y.545, W.548, M.549, V.552, Y.555, F.606
- Ligands: PLM.5, OLR.7, OLC.16, PLM.17
7 PLIP interactions:7 interactions with chain E- Hydrophobic interactions: E:Y.545, E:Y.545, E:W.548, E:W.548, E:V.552, E:Y.555, E:F.606
PLM.24: 5 residues within 4Å:- Ligands: PLM.8, OLC.23, PLM.25, PLM.27, POV.28
No protein-ligand interaction detected (PLIP)PLM.25: 5 residues within 4Å:- Chain F: G.594, I.595, F.596
- Ligands: PLM.9, PLM.24
3 PLIP interactions:3 interactions with chain F- Hydrophobic interactions: F:F.596, F:F.596
- Hydrogen bonds: F:I.595
PLM.26: 5 residues within 4Å:- Chain A: C.549
- Chain F: L.811, Y.819, I.822, L.825
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:L.811, F:Y.819, F:I.822, F:L.825
PLM.27: 10 residues within 4Å:- Chain F: Y.545, W.548, M.549, V.552, Y.555, F.606
- Ligands: PLM.8, OLR.10, OLC.23, PLM.24
7 PLIP interactions:7 interactions with chain F- Hydrophobic interactions: F:Y.545, F:Y.545, F:W.548, F:W.548, F:V.552, F:Y.555, F:F.606
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.4: 12 residues within 4Å:- Chain A: G.534, V.535, F.536, Y.818, I.819, V.821, G.823, L.826
- Chain B: A.117, A.167, I.174
- Ligands: OLC.2
7 PLIP interactions:6 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:F.536, A:Y.818, A:Y.818, A:I.819, A:V.821, A:L.826, B:A.167
POV.14: 9 residues within 4Å:- Chain C: A.117, I.174
- Chain D: G.534, V.535, F.536, Y.818, I.819, L.826
- Ligands: OLC.12
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:F.536, D:L.826
POV.21: 5 residues within 4Å:- Chain E: V.536, F.537, L.827
- Ligands: OLC.16, PLM.17
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:F.537, E:L.827
- Hydrogen bonds: E:V.536
POV.28: 6 residues within 4Å:- Chain F: V.536, F.537, Y.819, L.827
- Ligands: OLC.23, PLM.24
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:F.537, F:Y.819, F:L.827
- Hydrogen bonds: F:V.536
- 2 x OLR: 6-[(1~{S})-1-[1-[5-(2-hydroxyethyloxy)pyridin-2-yl]pyrazol-3-yl]ethyl]-3~{H}-1,3-benzothiazol-2-one(Non-covalent)
OLR.7: 14 residues within 4Å:- Chain B: M.35, W.44, N.172, V.176, Y.199, F.205, Y.206, G.208, G.209
- Chain E: Y.545, E.546, M.549, F.553
- Ligands: PLM.20
13 PLIP interactions:4 interactions with chain E, 9 interactions with chain B- Hydrophobic interactions: E:Y.545, E:E.546, E:F.553, E:F.553, B:V.176, B:F.205, B:Y.206
- Hydrogen bonds: B:N.172, B:N.172, B:Y.199, B:Y.206
- pi-Stacking: B:Y.201, B:F.205
OLR.10: 14 residues within 4Å:- Chain C: M.35, W.44, N.172, V.176, Y.199, F.205, Y.206, G.208, G.209
- Chain F: Y.545, E.546, M.549, F.553
- Ligands: PLM.27
13 PLIP interactions:4 interactions with chain F, 9 interactions with chain C- Hydrophobic interactions: F:Y.545, F:E.546, F:F.553, F:F.553, C:V.176, C:F.205, C:Y.206
- Hydrogen bonds: C:N.172, C:N.172, C:Y.199, C:Y.206
- pi-Stacking: C:Y.201, C:F.205
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Modulatory mechanisms of TARP gamma 8-selective AMPA receptor therapeutics. Nat Commun (2023)
- Release Date
- 2023-04-19
- Peptides
- Isoform Flip of Glutamate receptor 2: AD
Voltage-dependent calcium channel gamma-8 subunit: BC
Isoform Flip of Glutamate receptor 1: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
DB
IC
JE
CF
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 4 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 14 x PLM: PALMITIC ACID(Non-covalent)(Non-functional Binders)
- 4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x OLR: 6-[(1~{S})-1-[1-[5-(2-hydroxyethyloxy)pyridin-2-yl]pyrazol-3-yl]ethyl]-3~{H}-1,3-benzothiazol-2-one(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, D. et al., Modulatory mechanisms of TARP gamma 8-selective AMPA receptor therapeutics. Nat Commun (2023)
- Release Date
- 2023-04-19
- Peptides
- Isoform Flip of Glutamate receptor 2: AD
Voltage-dependent calcium channel gamma-8 subunit: BC
Isoform Flip of Glutamate receptor 1: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
DB
IC
JE
CF
A - Membrane
-
We predict this structure to be a membrane protein.